ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,137Medicare Part D Prescriptions Filled, Including Refills

Rank: 93 out of 890

$1.05M Total Retail Price of All Prescriptions

Rank: 47 out of 890

742 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 742 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

13% of this provider’s 742 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 11,544 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 549 457 1 5
AMLODIPINE BESYLATE 499 411 2 1
LISINOPRIL 475 391 3 4
ATORVASTATIN CALCIUM 394 291 4 13
HYDROCODONE-ACETAMINOPHEN 391 217 S3 5 3
METFORMIN HCL 378 305 6 6
ZOLPIDEM TARTRATE 377 280 7 19
LEVOTHYROXINE SODIUM 351 330 8 2
OMEPRAZOLE 313 261 9 8
ALPRAZOLAM 307 217 10 95
FUROSEMIDE 285 240 11 7
HYDROCHLOROTHIAZIDE 281 239 12 9
PANTOPRAZOLE SODIUM 271 231 13 34
LOSARTAN POTASSIUM 260 204 14 29
METOPROLOL TARTRATE 240 194 15 15
PRAVASTATIN SODIUM 213 197 16 10
FLUTICASONE PROPIONATE 200 165 17 39
CITALOPRAM HBR 180 126 18 20
PROAIR HFA 171 118 19 55
GABAPENTIN 170 103 20 12
ALLOPURINOL 155 142 21 31
ENALAPRIL MALEATE 150 86 22 56
METOPROLOL SUCCINATE 149 102 23 17
CRESTOR 138 119 24 25
AZITHROMYCIN 136 96 25 37
IRBESARTAN 134 110 26 332
WARFARIN SODIUM 132 90 27 24
INSULIN SYRINGE 126 98 28 99
CARVEDILOL 120 83 29 22
ATENOLOL 117 94 30 23
ALENDRONATE SODIUM 116 109 31 38
ESCITALOPRAM OXALATE 113 89 32 51
NEXIUM 111 81 33 14
TAMSULOSIN HCL 108 100 34 32
LOVASTATIN 107 86 35 46
TRAMADOL HCL 106 85 36 16
ADVAIR DISKUS 102 81 37 52
RANITIDINE HCL 99 89 38 49
POTASSIUM CHLORIDE 96 71 39 11
CLOPIDOGREL 94 76 40 28
BUPROPION XL 93 58 41 190
SPIRIVA 91 72 42 66
LORAZEPAM 89 86 43 195
DIOVAN 88 71 44 33
TRAZODONE HCL 86 54 45 40
TRIAMTERENE-HCTZ 85 61 46 61
AMITRIPTYLINE HCL 82 54 R 47 43
TEMAZEPAM 80 39 48 222
ACTOS 79 58 49 88
GLIMEPIRIDE 76 44 50 27
LOSARTAN-HYDROCHLOROTHIAZIDE 76 63 50 57
LANTUS 75 41 52 50
CLONAZEPAM 74 42 53 202
PLAVIX 73 59 54 42
DONEPEZIL HCL 67 60 55 30
TRAMADOL HCL-ACETAMINOPHEN 66 47 56 117
GLYBURIDE 66 51 R 56 83
GLIPIZIDE 65 47 58 62
FINASTERIDE 65 55 58 108
CYMBALTA 65 26 58 45
COMBIVENT 64 31 61 144
ONDANSETRON HCL 64 38 61 306
ISOSORBIDE MONONITRATE ER 64 46 61 60
DIAZEPAM 63 34 64 278
ZOLPIDEM TARTRATE ER 62 51 65 336
SULFAMETHOXAZOLE-TRIMETHOPRIM 61 47 66 76
ZETIA 59 44 67 81
DIGOXIN 59 53 67 65
METFORMIN HCL ER 57 57 69 54
FENTANYL 56 47 S2 70 151
SERTRALINE HCL 56 39 70 26
PREDNISONE 55 48 72 47
SYNTHROID 51 26 73 53
DOXAZOSIN MESYLATE 51 41 73 70
CYCLOBENZAPRINE HCL 51 0 R 73 64
SYMBICORT 50 41 76 174
OXYCODONE HCL-ACETAMINOPHEN 50 30 S2 76 127
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 13, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.